Unique protein signature of circulating microparticles in systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 65, Issue 10, 2013, Pages 2680-2690

  Østergaard, Ole ^a   Nielsen, Christoffer T ^a   Iversen, Line V ^b   Tanassi, Julia T ^a   Knudsen, Steen ^c   Jacobsen, Søren ^d   Heegaard, Niels H H ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c Medical Prognosis Institute   (Denmark)

^d Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; FICOLIN; FICOLIN 2; GALECTIN 3; IMMUNOGLOBULIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MEMBRANE PROTEIN; MICROPARTICLE PROTEIN; MICROTUBULE PROTEIN; PROTEIN 14 3 3; PROTEIN 14 3 3 ETA; PROTEOME; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; CENTRIFUGATION; CLINICAL ARTICLE; CYTOSKELETON; DISEASE SEVERITY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; THROMBOCYTE POOR PLASMA; UPREGULATION;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CELL-DERIVED MICROPARTICLES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEMBRANE PROTEINS; MICROTUBULE PROTEINS; MIDDLE AGED; MITOCHONDRIAL PROTEINS; PROTEINS; SCLERODERMA, SYSTEMIC;

EID: 84885136150     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.38065     Document Type: Article

References (51)

1. Elkon KB, Wiedeman A,. Type I IFN system in the development and manifestations of SLE. Curr Opin Rheumatol 2012; 24: 499-505.
2. Munoz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M,. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol 2010; 6: 280-9.
3. Scott RS, McMahon EJ, Pop SM, Reap EA, Caricchio R, Cohen PL, et al. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 2001; 411: 207-11.
4. Botto M, Dell'Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 1998; 19: 56-9.
5. Taylor PR, Carugati A, Fadok VA, Cook HT, Andrews M, Carroll MC, et al. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med 2000; 192: 359-66.
6. Peng Y, Elkon KB,. Autoimmunity in MFG-E8-deficient mice is associated with altered trafficking and enhanced cross-presentation of apoptotic cell antigens [published erratum appears in J Clin Invest 2012;122:782]. J Clin Invest 2011; 121: 2221-41.
7. Kim SJ, Gershov D, Ma X, Brot N, Elkon KB,. Opsonization of apoptotic cells and its effect on macrophage and T cell immune responses. Ann N Y Acad Sci 2003; 987: 68-78.
8. Martin M, Leffler J, Blom AM,. Annexin A2 and A5 serve as new ligands for C1Q on apoptotic cells. J Biol Chem 2012; 287: 33733-44.
9. Napirei M, Karsunky H, Zevnik B, Stephan H, Mannherz HG, Moroy T,. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 2000; 25: 177-81.
10. Nielsen CT, Ostergaard O, Johnsen C, Jacobsen S, Heegaard NH,. Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus. Arthritis Rheum 2011; 63: 3067-77.
11. Nielsen CT, Ostergaard O, Stener L, Iversen LV, Truedsson L, Gullstrand B, et al. Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation. Arthritis Rheum 2012; 64: 1227-36.
12. Ullal AJ, Reich CF III, Clowse M, Criscione-Schreiber LG, Tochacek M, Monestier M, et al. Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus. J Autoimmun 2011; 36: 173-80.
13. Bilyy RO, Shkandina T, Tomin A, Munoz LE, Franz S, Antonyuk V, et al. Macrophages discriminate glycosylation patterns of apoptotic cell-derived microparticles. J Biol Chem 2012; 287: 496-503.
14. Dragovic RA, Gardiner C, Brooks AS, Tannetta DS, Ferguson DJ, Hole P, et al. Sizing and phenotyping of cellular vesicles using nanoparticle tracking analysis. Nanomedicine 2011; 7: 780-8.
15. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.
16. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
17. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
18. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630-40.
19. Cox J, Mann M,. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 2008; 26: 1367-72.
20. Cox J, Neuhauser N, Michalski A, Scheltema RA, Olsen JV, Mann M,. Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res 2011; 10: 1794-805.
21. The UniProt Consortium. Reorganizing the protein space at the Universal Protein Resource (UniProt). Nucleic Acids Res 2012; 40: D71-5.
22. Ostergaard O, Nielsen CT, Iversen LV, Jacobsen S, Tanassi JT, Heegaard NH,. Quantitative proteome profiling of normal human circulating microparticles. J Proteome Res 2012; 11: 2154-63.
23. Manheimer-Lory A, Katz JB, Pillinger M, Ghossein C, Smith A, Diamond B,. Molecular characteristics of antibodies bearing an anti-DNA-associated idiotype. J Exp Med 1991; 174: 1639-52.
24. Wade RH,. Microtubules: an overview. Methods Mol Med 2007; 137: 1-16.
25. Lovgren T, Eloranta ML, Bave U, Alm GV, Ronnblom L,. Induction of interferon-α production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum 2004; 50: 1861-72.
26. Schiller M, Parcina M, Heyder P, Foermer S, Ostrop J, Leo A, et al. Induction of type I IFN is a physiological immune reaction to apoptotic cell-derived membrane microparticles. J Immunol 2012; 189: 1747-56.
27. Gyorgy B, Modos K, Pallinger E, Paloczi K, Pasztoi M, Misjak P, et al. Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters. Blood 2011; 117: e39-48.
28. Eisenberg RA, Theofilopoulos AN, Dixon FJ,. Use of bovine conglutinin for the assay of immune complexes. J Immunol 1977; 118: 1428-34.
29. Tung KS, DeHoratius RJ, Williams RC,. Study of circulating immune complex size in systemic lupus erythematosus. Clin Exp Immunol 1981; 43: 615-25.
30. Van der Pol E, van Gemert MJ, Sturk A, Nieuwland R, van Leeuwen TG,. Single vs. swarm detection of microparticles and exosomes by flow cytometry. J Thromb Haemost 2012; 10: 919-30.
31. Mathivanan S, Lim JW, Tauro BJ, Ji H, Moritz RL, Simpson RJ,. Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature. Mol Cell Proteomics 2010; 9: 197-208.
32. 2-glycoprotein I in macrophage recognition. J Biol Chem 1997; 272: 31113-7.
33. Munoz LE, Peter C, Herrmann M, Wesselborg S, Lauber K,. Scent of dying cells: the role of attraction signals in the clearance of apoptotic cells and its immunological consequences. Autoimmun Rev 2010; 9: 425-30.
34. Jensen ML, Honore C, Hummelshoj T, Hansen BE, Madsen HO, Garred P,. Ficolin-2 recognizes DNA and participates in the clearance of dying host cells. Mol Immunol 2007; 44: 856-65.
35. 2-glycoprotein I: evolution, structure and function. J Thromb Haemost 2011; 9: 1275-84.
36. Xu Z, Zan H, Pone EJ, Mai T, Casali P,. Immunoglobulin class-switch DNA recombination: induction, targeting and beyond. Nat Rev Immunol 2012; 12: 517-31.
37. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 2003; 100: 2610-5.
38. Sasaki T, Brakebusch C, Engel J, Timpl R,. Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds β1 integrins, collagens and fibronectin. EMBO J 1998; 17: 1606-13.
39. Yung S, Zhang Q, Zhang CZ, Chan KW, Lui SL, Chan TM,. Anti-DNA antibody induction of protein kinase C phosphorylation and fibronectin synthesis in human and murine lupus and the effect of mycophenolic acid. Arthritis Rheum 2009; 60: 2071-82.
40. Garcia BA, Smalley DM, Cho H, Shabanowitz J, Ley K, Hunt DF,. The platelet microparticle proteome. J Proteome Res 2005; 4: 1516-21.
41. Ansa-Addo EA, Lange S, Stratton D, Antwi-Baffour S, Cestari I, Ramirez MI, et al. Human plasma membrane-derived vesicles halt proliferation and induce differentiation of THP-1 acute monocytic leukemia cells. J Immunol 2010; 185: 5236-46.
42. Kropf J, Schurek JO, Wollner A, Gressner AM,. Immunological measurement of transforming growth factor-beta 1 (TGF-β1) in blood; assay development and comparison. Clin Chem 1997; 43: 1965-74.
43. Kohut E, Hajdu M, Gergely P, Gopcsa L, Kilian K, Paloczi K, et al. Expression of TGFβ1 and its signaling components by peripheral lymphocytes in systemic lupus erythematosus. Pathol Oncol Res 2009; 15: 251-6.
44. Becker-Merok A, Eilertsen GO, Nossent JC,. Levels of transforming growth factor-β are low in systemic lupus erythematosus patients with active disease. J Rheumatol 2010; 37: 2039-45.
45. Eken C, Sadallah S, Martin PJ, Treves S, Schifferli JA,. Ectosomes of polymorphonuclear neutrophils activate multiple signaling pathways in macrophages. Immunobiology 2013; 218: 382-92.
46. Hakkim A, Furnrohr BG, Amann K, Laube B, Abed UA, Brinkmann V, et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci U S A 2010; 107: 9813-8.
47. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM,. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J Clin Invest 1998; 101: 890-8.
48. Carlsen AL, Schetter AJ, Nielsen CT, Lood C, Knudsen S, et al. Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum 2013; 65: 1324-34.
49. Falcon-Perez JM, Nazarian R, Sabatti C, Dell'Angelica EC,. Distribution and dynamics of Lamp1-containing endocytic organelles in fibroblasts deficient in BLOC-3. J Cell Sci 2005; 118: 5243-55.
50. Cook NR, Row PE, Davidson HW,. Lysosome associated membrane protein 1 (Lamp1) traffics directly from the TGN to early endosomes. Traffic 2004; 5: 685-99.
51. Alessandri C, Barbati C, Vacirca D, Piscopo P, Confaloni A, Sanchez M, et al. T lymphocytes from patients with systemic lupus erythematosus are resistant to induction of autophagy. FASEB J 2012; 26: 4722-32.